Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between response to triptans and response to erenumab: real-life data.
Frattale I, Caponnetto V, Casalena A, Assetta M, Maddestra M, Marzoli F, Affaitati G, Giamberardino MA, Viola S, Gabriele A, Pistoia F, Cerone D, Marini C, Sacco S, Ornello R. Frattale I, et al. Among authors: caponnetto v. J Headache Pain. 2021 Jan 6;22(1):1. doi: 10.1186/s10194-020-01213-3. J Headache Pain. 2021. PMID: 33407070 Free PMC article.
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN).
Filippi M, Messina R, Bartezaghi M, Cetta I, Colombo B, Grazzi L, Martinelli D, Ornello R, Pichiecchio A, Raimondi D, Russo A, Sacco S, Splendiani A, Tassorelli C, Turrini R, Valsasina P, Rocca MA; RESET BRAIN Study Group. Filippi M, et al. J Neurol. 2023 Nov;270(11):5600-5612. doi: 10.1007/s00415-023-11879-9. Epub 2023 Aug 8. J Neurol. 2023. PMID: 37550498 Free PMC article. Clinical Trial.
Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study.
De Matteis E, Caponnetto V, Casalena A, Frattale I, Gabriele A, Affaitati G, Giamberardino MA, Maddestra M, Viola S, Pistoia F, Sacco S, Ornello R. De Matteis E, et al. Among authors: caponnetto v. Front Neurol. 2022 Sep 23;13:973226. doi: 10.3389/fneur.2022.973226. eCollection 2022. Front Neurol. 2022. PMID: 36212640 Free PMC article.
Hallmarks of primary headache: part 1 - migraine.
Raggi A, Leonardi M, Arruda M, Caponnetto V, Castaldo M, Coppola G, Della Pietra A, Fan X, Garcia-Azorin D, Gazerani P, Grangeon L, Grazzi L, Hsiao FJ, Ihara K, Labastida-Ramirez A, Lange KS, Lisicki M, Marcassoli A, Montisano DA, Onan D, Onofri A, Pellesi L, Peres M, Petrušić I, Raffaelli B, Rubio-Beltran E, Straube A, Straube S, Takizawa T, Tana C, Tinelli M, Valeriani M, Vigneri S, Vuralli D, Waliszewska-Prosół M, Wang W, Wang Y, Wells-Gatnik W, Wijeratne T, Martelletti P. Raggi A, et al. Among authors: caponnetto v. J Headache Pain. 2024 Oct 31;25(1):189. doi: 10.1186/s10194-024-01889-x. J Headache Pain. 2024. PMID: 39482575 Free PMC article. Review.
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance.
Sacco S, Lampl C, Maassen van den Brink A, Caponnetto V, Braschinsky M, Ducros A, Little P, Pozo-Rosich P, Reuter U, Ruiz de la Torre E, Sanchez Del Rio M, Sinclair AJ, Martelletti P, Katsarava Z; Burden and Attitude to Resistant and Refractory (BARR) Study Group. Sacco S, et al. Among authors: caponnetto v. J Headache Pain. 2021 May 18;22(1):39. doi: 10.1186/s10194-021-01252-4. J Headache Pain. 2021. PMID: 34006218 Free PMC article.
56 results